Gamboa Ricardo, Jaramillo-Estrella María José, Martínez-Alvarado María Del Rocio, Soto Maria Elena, Torres-Paz Yazmin Estela, Gonzalo-Calvo David de, Del Valle-Mondragón Leonardo, López-Marure Rebeca, Llorente-Cortés Vicenta C, Huesca-Gómez Claudia
Instituto Nacional de Cardiologia Ignacio Chavez, Ciudad de México - México.
Hospital de Sant Pau - Lipids and Cardiovascular Pathology Group, Barcelona, Catalunya - Espanha.
Arq Bras Cardiol. 2021 Jan;116(1):56-65. doi: 10.36660/abc.20190535.
Arterial hypertension (HTA) represents a major risk factor for cardiovascular morbidity and mortality. It is not yet known which specific molecular mechanisms are associated with the development of essential hypertension.
In this study, we analyzed the association between LRP1 monocyte mRNA expression, LRP1 protein expression, and carotid intima media thickness (cIMT) of patients with essential hypertension.
The LRP1 monocyte mRNA expression and protein levels and cIMT were quantified in 200 Mexican subjects, 91 normotensive (NT) and 109 hypertensive (HT). Statistical significance was defined as p < 0.05.
HT patients group had highly significant greater cIMT as compared to NT patients (p=0.002) and this correlated with an increase in the expression of LRP1 mRNA expression (6.54 vs. 2.87) (p = 0.002) and LRP1 protein expression (17.83 vs. 6.25), respectively (p = 0.001). These differences were maintained even when we divided our study groups, taking into account only those who presented dyslipidemia in both, mRNA (p = 0.041) and proteins expression (p < 0.001). It was also found that Ang II mediated LRP1 induction on monocytes in a dose and time dependent manner with significant difference in NT vs. HT (0.195 ± 0.09 vs. 0.226 ± 0.12, p = 0.046).
An increase in cIMT was found in subjects with hypertension, associated with higher mRNA and LRP1 protein expressions in monocytes, irrespective of the presence of dyslipidemias in HT patients. These results suggest that LRP1 upregulation in monocytes from Mexican hypertensive patients could be involved in the increased cIMT. (Arq Bras Cardiol. 2021; 116(1):56-65).
动脉高血压(HTA)是心血管疾病发病和死亡的主要危险因素。目前尚不清楚哪些特定分子机制与原发性高血压的发生有关。
在本研究中,我们分析了原发性高血压患者中低密度脂蛋白受体相关蛋白1(LRP1)单核细胞mRNA表达、LRP1蛋白表达与颈动脉内膜中层厚度(cIMT)之间的关联。
对200名墨西哥受试者(91名血压正常者(NT)和109名高血压患者(HT))的LRP1单核细胞mRNA表达、蛋白水平和cIMT进行了定量分析。统计学显著性定义为p < 0.05。
与NT患者相比,HT患者组的cIMT显著更高(p = 0.002),这分别与LRP1 mRNA表达增加(6.54对2.87)(p = 0.002)和LRP1蛋白表达增加(17.83对6.25)相关(p = 0.001)。即使我们仅考虑两组中均存在血脂异常的患者来划分研究组,这些差异在mRNA(p = 0.041)和蛋白表达(p < 0.001)方面仍然存在。还发现,血管紧张素II以剂量和时间依赖性方式介导单核细胞上的LRP1诱导,NT与HT之间存在显著差异(0.195±0.09对0.226±0.12,p = 0.046)。
高血压患者的cIMT增加,与单核细胞中更高的mRNA和LRP1蛋白表达相关,无论HT患者是否存在血脂异常。这些结果表明,墨西哥高血压患者单核细胞中LRP1的上调可能与cIMT增加有关。(《巴西心脏病学杂志》。2021年;116(1):56 - 65)